UNDERSTANDING THE INTERACTION BETWEEN GLUTATHIONE AND ACETAMINOPHEN: A DOCKING STUDY APPROACH
Abstract
Keywords
Full Text:
PDFReferences
Corrêa A, De Almeida V, Lopes B, Franco A, De Matos F, Quintans-JúniorLj, Rode SM, Paranhos LR, The influence of non-steroidal anti-inflammatory drugs and paracetamol used for pain control of orthodontic tooth movement: a systematic review. An. Acad. Bras. Ciênc. 2017; 89(4):2851-2863
Anderson, B.J. paracetamol (acetaminophen): Mechanisms of action, Pediatric Anesthesia. 2015; 18(10), 915-921.
Jozwiak-Bebenista, M., Nowak, J.Z. Paracetamol: Mechanism of action, applications and safety concern. ActaPoloniaePharmaceutica – Drug Research. 2014; 71(1), 11-23.
Du, K., Ramachandran, A., Jaeschke, H. Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biology 2016; 10, 148-156.
Moyer, A.M., Fridley, B.L., Jenkins, G.D., Batzler, A.J., Pelleymounter, L.L., Kalari, K.R., Ji, Y., Chai, Y., Nordgren, K.K.S., Weinshilboum, R.M. Adetaminophen-NAPQI hepatotoxicity: A cell line model system genome-wide association study. Toxicological Sciences. 2011; 120(1), 33-41.
Dai, J., Mumper, R.J. Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Molecules. 2010; 15(10), 7313-7352.
Meiyanto, E., Putri, D.D., Susidarti, R.A., Murwanti, R., Sardjiman, Fitriasari, A., Husnaa, U., Purnomo, H., Kawaichi, M. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation. Asian Pacific Journal of Cancer Prevention.2014; 15(1), 179-184.
Lee, H.Y., Kim, S.W., Lee, G.H., Choi, M.K., Jung, H.W., Kim, J.Y., Kwon, H.J., Chae, H.J. 2016. Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation. BMC Complementary and Alternative Medicine. 2016; 16(1), 316
Burgos-Moron, E., Calderon-Montano, J.M., Salvador, J., Robles, A., Lopez-Lazaro, M. The dark side of curcumin. International Journal of Cancer. 2010;126(7), 1771-1775.
Kurien, B.T., Dillon, S.P., Dorri, Y., D’Souza, A., Scofield, R.H. Curcumin does not bind or intercalate into DNA and a note on the gray side of curcumin. International Journal of Cancer. 2011; 128(1), 242-245.
Tokarz, P., Kaarniranta, K., Blasiak, J. Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology. 2013; 14(5), 461-482.
Fitri, L.E., Iskandar, A., Sardjono, T.W., Erliana, U.D., Rahmawati, W., Candradikusuma, D., Saputra, U.B., Suhartono, E., Setiawan, B., Sulistyaningsih, E. Plasma glutathione and oxidized glutathione level, glutathione/oxidized glutathione ratio, and albumin concentration in complexed and uncompilcated falciparum malaria. Asian Pacific Journal of Tropical Biomedicine. 2016; 6(8), 646-650.
Letelier, M.E., Molina-Berrios, A., Cortes-Tronsoco, J., Jara-Sandoval, J., Holst, M., Palma, K., Montoya, M., Miranda, D., Gonzales-Lira, V. DPPH and oxigen free radicals as pro-oxidant of biomolecules. Toxicology In Vitro. 2008; 22(2), 279-286.
Balcerczyk, A., Bartosz, G. Thiols are main determinants of total antioxidant capacity of cellular homogenates. Free Radical Research. 2003; 37(5), 537-541.
Deneke, S.M., Thiol-based antioxidants. Current Topics in Cellular Regulation, 2008; 36(2001), 151-180.
Levy, Y., Papoian, G.A., Onuchic, J.N., Wolynes, P.G. Energy landscape analysis of protein dimers. Israel Journal of Chemistry. 2004; 44(1-3), 281-297.
Ranganathan, P.N., Whalen, R., Boyer, T.D. Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes. Biochemical Journal.2005; 386(Pt 3), 525-533.
Deponte, M. Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. BiochimicaetBiophysicaActa. 2003; 1830(5), 3217-3266.
Cosconati, S., Forli, S., Perryman, A.L., Harris, R., Goodsell, D.S., Olson, A.J. 2010. Virtual screening with autodock: Theory and practice. Expert Opinion on Drug Discovery. 2010; 5(6), 597-607.
Pratama, M.R.F., Gusdinar, T. Between artemisinin and derivatives with neuraminidase: A docking study insight. Asian Journal of Pharmaceutical and Clinical Research, 10(8), 304-308.
O’Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., Hutchison, G.R. Open babel: An open chemical toolbox. Journal of Cheminformatics. 2012; 3: 33-40.
Pratama, M.R.F., Sutomo, S. Chemical structure optimization of lupeol as ER-A and HER2 inhibitor. Asian Journal of Pharmaceutical and Clinical Research. 2018; 11(6), 298-303.
Trott, O., Olson, A.J. Autodockvina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry. 2010; 31(2), 455-461.
Pratama, M.R.F. Akarkuning (arcangelisiaflava) sebagai inhibitor EGFR: Kajian in silico. JurnalFarmagazine. 2016; 3(1), 6-16.
Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J. Autodock 4 and autodocktools: Automated docking with selective receptor flexibility. Journal of Computational Chemistry. 2009; 30(16), 2785-2791.
Meng, X.Y., Zhang, H.X., Mezei, M., Cui, M. Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design.2011; 7(2), 146-157.
Pratama, M.R.F. Studi docking molekularsenyawaturunankuinolinterhadapreseptor estrogen-α. Jurnal Surya Medika, 2016; 2(1), 1-7
Pratama, M.R.F. Molecular docking of anticancer agents: Artemisinin and derivatives as HER2 inhibitor. In D. Mahdiyah (Eds), Proceeding Sari Mulia International Conference on Health and Sciences. 2015; 155-168. Banjarmasin: LPPM AKBID.
Kim, R., Skolnick, J. Assesment of programs for ligand binding affinity prediction. Journal of Computational Chemistry, 2015; 29(8), 1316-1331.
Thomas, C., Moraga, I., Levin, D., Krutzik, P.O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S.E., Glenn, J.S., Nolan, G.P., Piehler, J., Schreiber, G., Garcia, K.C. Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell. 2011; 146(4), 621-632.
Kontoyianni, M., McClellan, L.M., Sokol, G.S. Evaluation of docking performance: Comparative data on docking algorithms. Journal of Medicinal Chemistry.2004; 47(3), 558-565
Pratama, M.R.F., Pratomo, G.S. 2017. Pharmacophore optimization of berberine as HER2 inhibitor. JurnalFarmasi Indonesia.2017; 14(2), 109-117.
Pratama, M.R.F. 2016. Studi in silicoafinitaskatinondanmetabolitnyaterhadapreseptordopamin D1dan D2. In PoliteknikKesehatanKemenkesPalangka Raya, Prosiding Seminar NasionalPenatalaksanaanPenyalahgunaanNarkobaBerbasisKeluarga. 122-129. Palangka Raya: PoliteknikKesehatanKemenkesPalangka Raya.
Purwanto, B., Prasetyo, D.H., 2012. Effect of oral N-acetylcysteinetratment on immune system in continuous ambulatory peritoneal dialysis patients. ActaMedicaIndonesiana, 44(2), 140-144.
DOI: http://dx.doi.org/10.20527/dentino.v3i2.5381
DOI (PDF): http://dx.doi.org/10.20527/dentino.v3i2.5381.g4541
Article Metrics
Abstract view : 944 timesPDF - 303 times
Refbacks
- There are currently no refbacks.
Contact Us:
Faculty of Dentistry
Lambung Mangkurat University
Jalan Veteran No. 128 B Banjarmasin, Indonesia
E-mail. [email protected]
Website. fkg.ulm.ac.id
This work is licensed under a Creative Commons Attribution 4.0 International License.